Seminars in Oncology
Volume 36, Supplement 1 , Pages S20-S26, April 2009

Proteasome Inhibitors in Multiple Myeloma

  • Kenneth C. Anderson

      Affiliations

    • Corresponding Author InformationAddress correspondence to Kenneth C. Anderson, MD, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Mayer 557, 44 Binney St, Boston, MA 02115

Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Dr Anderson is supported by funding from Cephalon Oncology.

PII: S0093-7754(09)00029-3

doi:10.1053/j.seminoncol.2009.02.001

Seminars in Oncology
Volume 36, Supplement 1 , Pages S20-S26, April 2009

Article Tools

* Image Usage & Resolution